CERIBELL INC. - COMMON STOCK

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

20 May 2025 13:05:00 By Nasdaq GlobeNewswire

Ceribell Reports First Quarter 2025 Financial Results

08 May 2025 13:05:02 By Nasdaq GlobeNewswire

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

30 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems

30 Apr 2025 05:00:00 By Nasdaq GlobeNewswire

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

24 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

15 Apr 2025 05:00:00 By Nasdaq GlobeNewswire

Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results

25 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference

18 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

11 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

23 Dec 2024 13:05:00 By Nasdaq GlobeNewswire

Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing

19 Nov 2024 05:00:00 By Nasdaq GlobeNewswire

Ceribell Reports Third Quarter 2024 Financial Results

12 Nov 2024 13:05:01 By Nasdaq GlobeNewswire

Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs

11 Nov 2024 05:00:00 By Nasdaq GlobeNewswire

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

07 Nov 2024 13:05:01 By Nasdaq GlobeNewswire